全球人类白细胞抗原 (HLA) 分型移植诊断服务市场 – 行业趋势和 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球人类白细胞抗原 (HLA) 分型移植诊断服务市场 – 行业趋势和 2029 年预测

  • Healthcare
  • Upcoming Report
  • Jan 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Hla Typing Transplant Diagnostics Services Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2029
Diagram Market Size (Base Year)
USD MILLION
Diagram Market Size (Forecast Year)
USD MILLION
Diagram CAGR
%
Diagram Major Markets Players
  • Thermo Fisher Scientific
  • AbbVie
  • F. Hoffmann-La Roche Ltd
  • Illumina
  • QIAGEN

>全球人类白细胞抗原 (HLA) 分型移植诊断服务市场,按产品和服务(仪器、试剂和消耗品、软件和服务)、应用(诊断和研究)、最终用户(医院、学术和研究机构)、最终用户(直接招标、医院药房、零售药房、网上药房等)、技术(聚合酶链反应和下一代测序)、国家(美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区)行业趋势和预测到 2029 年。

人类白细胞抗原 (HLA) 分型移植诊断服务市场

人类白细胞抗原 (HLA) 分型移植诊断服务市场的市场分析和见解

Data Bridge Market Research 分析,人类白细胞抗原 (HLA) 分型移植诊断服务市场在 2022-2029 年的预测期内将呈现约 9.45% 的复合年增长率。慢性病患病率的上升、对医疗器械研发能力和先进 IT 医疗技术的采用的关注度的提高、全球老年人口基数的增加以及医疗基础设施建设支出的增加(尤其是在发展中经济体)是人类白细胞抗原 (HLA) 分型移植诊断服务市场增长的主要因素。

人类白细胞抗原 (HLA) 分型是一种医疗程序,用于诊断患者和供体是否适合进行脐带血或骨髓移植。人类白细胞抗原 (HLA) 是体内的蛋白质,其检测是通过基于 DNA 的分子诊断程序进行的。   

公共和私营部门对目标研究活动的资助激增是促进市场增长的主要因素之一。实体器官和干细胞移植程序数量的增加是另一个市场增长的决定因素。技术进步和新仪器创新的不断提升、药物发现活动数量的激增、组织工程和再生医学应用的采用率的提高以及新兴市场的尚未开发的潜力将进一步产生有利可图的市场增长机会。

然而,分子检测成本的上升将影响市场增长率。此外,缺乏熟练的医疗专业人员、器官捐献者与器官数量之间的巨大差距以及发展中国家和欠发达经济体缺乏有利的报销方案将进一步给市场带来挑战。

This human leukocyte antigens (HLAs) typing transplant diagnostics services market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on human leukocyte antigens (HLAs) typing transplant diagnostics services market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Scope and Market Size

The human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented on the basis of product and services, application, end-user and technology. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of product and services, the human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented into instruments, reagents and consumables, software and services.
  • Based on application, the human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented into diagnostics and research.
  • Based on end-user, the human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented into hospitals, and academic and research institutes.
  • The human leukocyte antigens (HLAs) typing transplant diagnostics services market is also segmented on the basis of technology into polymerase chain reaction and next-generation sequencing. Polymerase chain reaction is further segmented into polymerase chain reaction - sequence-specific amplification (SSP), polymerase chain reaction sequence-specific oligonucleotides probes (PCR-SSOP) and polymerase chain reaction-sequencing-based typing (PCR-SBT).

Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Country Level Analysis

The human leukocyte antigens (HLAs) typing transplant diagnostics services market is segmented on the basis of product and services, application, end-user and technology.

The countries covered in the human leukocyte antigens (HLAs) typing transplant diagnostics services market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the human leukocyte antigens (HLAs) typing transplant diagnostics services market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the increase in the expenditure for research and development proficiencies, rising technological advancements in the field of transplant diagnostics and large volume of organ transplantation procedures. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period owing to the increasing government expenditure on healthcare sector, ever-rising geriatric population base, increased adoption of innovative transplant diagnostic technologies and rising personal disposable income.

The country section of the human leukocyte antigens (HLAs) typing transplant diagnostics services market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The human leukocyte antigens (HLAs) typing transplant diagnostics services market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for human leukocyte antigens (HLAs) typing transplant diagnostics services market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the human leukocyte antigens (HLAs) typing transplant diagnostics services market. The data is available for historic period 2010 to 2020.

Competitive Landscape and Human Leukocyte Antigens (HLAs) Typing Transplant Diagnostics Services Market Share Analysis

人类白细胞抗原 (HLA) 分型移植诊断服务市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对人类白细胞抗原 (HLA) 分型移植诊断服务市场的关注有关。

人类白细胞抗原 (HLA) 分型移植诊断服务市场报告中的一些主要参与者包括 Thermo Fisher Scientific Inc.、AbbVie Inc.、F. Hoffmann-La Roche Ltd、Illumina, Inc.、QIAGEN、Immucor, Inc.、Bio-Rad Laboratories, Inc.、Luminex Corporation.、CareDx, Inc.、GenDx、Voden Medical Instruments Spa、TBG Diagnostics Limited、ProImmune Ltd、Pacific Biosciences of California, Inc、Omixon Inc.、omicX、MC Diagnostics Ltd、Integrated Gulf Biosystems、InGen 和 Hologic, Inc. 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

North America dominates the human leukocyte antigens (HLAs) typing transplant diagnostics services market in terms of market share and market revenue.
The growth rate of the human leukocyte antigens (HLAs) typing transplant diagnostics services market is 9.45% by 2029.
Upsurge in the public-private funding for target research activities & rising number of solid organ and stem cell transplantation procedures are the growth drivers of the human leukocyte antigens (HLAs) typing transplant diagnostics services market.
Product and services, application, end-user, and technology are the factors on which the human leukocyte antigens (HLAs) typing transplant diagnostics services market research is based.
Major companies in the human leukocyte antigens (HLAs) typing transplant diagnostics services market report are Thermo Fisher Scientific Inc., AbbVie Inc., F. Hoffmann-La Roche Ltd, Illumina, Inc., QIAGEN, Immucor, Inc., Bio-Rad Laboratories, Inc., Luminex Corporation., CareDx, Inc., GenDx, Voden Medical Instruments S.p.a., TBG Diagnostics Limited, ProImmune Ltd, Pacific Biosciences of California, Inc, Omixon Inc., omicX, MC Diagnostics Ltd, Integrated Gulf Biosystems, InGen and Hologic, Inc., among others.